These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 1323998

  • 1. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S, Spindel ER, Rubin NH, Singh P.
    Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
    [Abstract] [Full Text] [Related]

  • 2. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
    Narayan S, Guo YS, Townsend CM, Singh P.
    Cancer Res; 1990 Nov 01; 50(21):6772-8. PubMed ID: 2208141
    [Abstract] [Full Text] [Related]

  • 3. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
    Thomas F, Arvelo F, Antoine E, Jacrot M, Poupon MF.
    Cancer Res; 1992 Sep 15; 52(18):4872-7. PubMed ID: 1325285
    [Abstract] [Full Text] [Related]

  • 4. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    Wu JM, Hoang DO, Feldman RI.
    Mol Pharmacol; 1995 Apr 15; 47(4):871-81. PubMed ID: 7723750
    [Abstract] [Full Text] [Related]

  • 5. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
    Mahmoud S, Staley J, Taylor J, Bogden A, Moreau JP, Coy D, Avis I, Cuttitta F, Mulshine JL, Moody TW.
    Cancer Res; 1991 Apr 01; 51(7):1798-802. PubMed ID: 1848479
    [Abstract] [Full Text] [Related]

  • 6. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
    Mantey S, Frucht H, Coy DH, Jensen RT.
    Mol Pharmacol; 1993 May 01; 43(5):762-74. PubMed ID: 7684815
    [Abstract] [Full Text] [Related]

  • 7. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
    Benya RV, Wada E, Battey JF, Fathi Z, Wang LH, Mantey SA, Coy DH, Jensen RT.
    Mol Pharmacol; 1992 Dec 01; 42(6):1058-68. PubMed ID: 1336112
    [Abstract] [Full Text] [Related]

  • 8. High-affinity binding sites for bombesin on mouse colonic mucosal membranes.
    Narayan S, Draviam E, Rajaraman S, Singh P.
    Mol Cell Biochem; 1991 Jul 24; 106(1):31-9. PubMed ID: 1656207
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
    Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K.
    Cancer Res; 1994 Nov 15; 54(22):5895-901. PubMed ID: 7954420
    [Abstract] [Full Text] [Related]

  • 10. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A, Schally AV, Varga JL, Hammann BD, Groot K, Halmos G, Cai RZ, Zarandi M.
    Prostate; 2005 Aug 01; 64(3):303-15. PubMed ID: 15754342
    [Abstract] [Full Text] [Related]

  • 11. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT, Coy DH, Mantey SA, Jensen RT.
    J Pharmacol Exp Ther; 1995 Oct 01; 275(1):285-95. PubMed ID: 7562561
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
    Kiaris H, Schally AV, Sun B, Armatis P, Groot K.
    Oncogene; 1999 Nov 25; 18(50):7168-73. PubMed ID: 10597318
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
    Qin Y, Ertl T, Cai RZ, Halmos G, Schally AV.
    Cancer Res; 1994 Feb 15; 54(4):1035-41. PubMed ID: 8313359
    [Abstract] [Full Text] [Related]

  • 14. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
    Radulovic S, Cai RZ, Serfozo P, Groot K, Redding TW, Pinski J, Schally AV.
    Int J Pept Protein Res; 1991 Dec 15; 38(6):593-600. PubMed ID: 1726427
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
    Stangelberger A, Schally AV, Varga JL, Zarandi M, Szepeshazi K, Armatis P, Halmos G.
    Clin Cancer Res; 2005 Jan 01; 11(1):49-57. PubMed ID: 15671527
    [Abstract] [Full Text] [Related]

  • 16. Systematic development of bombesin/gastrin-releasing peptide antagonists.
    Coy DH, Jensen RT, Jiang NY, Lin JT, Bogden AE, Moreau JP.
    J Natl Cancer Inst Monogr; 1992 Jan 01; (13):133-9. PubMed ID: 1389686
    [Abstract] [Full Text] [Related]

  • 17. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
    Williams BY, Schonbrunn A.
    Cancer Res; 1994 Feb 01; 54(3):818-24. PubMed ID: 8306345
    [Abstract] [Full Text] [Related]

  • 18. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH, Battey JF, Wada E, Lin JT, Mantey S, Coy DH, Jensen RT.
    Biochem J; 1992 Sep 01; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [Abstract] [Full Text] [Related]

  • 19. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM, Nitecki DE, Biancalana S, Feldman RI.
    Mol Pharmacol; 1996 Nov 01; 50(5):1355-63. PubMed ID: 8913368
    [Abstract] [Full Text] [Related]

  • 20. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
    Benya RV, Fathi Z, Kusui T, Pradhan T, Battey JF, Jensen RT.
    Mol Pharmacol; 1994 Aug 01; 46(2):235-45. PubMed ID: 8078487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.